NovaBay Pharmaceuticals, Inc. (NBY) announced a 1‑for‑5 reverse stock split that will consolidate every five existing shares into one new share. The split is scheduled to become effective at 4:15 p.m. New York City time on February 20 2026, with trading on a split‑adjusted basis beginning February 23 2026.
The reverse split is a direct response to the company’s recent compliance notices from NYSE American. NovaBay has received multiple warnings for falling below the exchange’s minimum stockholders’ equity requirement. By increasing the per‑share price, the company aims to meet the minimum bid‑price threshold and avoid a potential delisting.
While the split does not alter NovaBay’s market capitalization or the total value of investors’ holdings, it does reduce the number of outstanding shares, which can affect liquidity and the ability of smaller investors to trade the stock. The move is therefore primarily a defensive measure rather than an indicator of improved financial performance.
NovaBay’s recent financial results underscore the need for the split. In Q1 2024 the company reported a net loss of $3.6 million, compared with a $1.7 million loss in Q1 2023. Net product sales rose 13 % to $2.6 million in Q1 2024 from $2.3 million a year earlier, but the company still posted a net loss attributable to common stockholders of $9.2 million in Q4 2023, or $1.33 per share. These figures illustrate ongoing profitability challenges and a declining cash position.
The company’s business model has also shifted. NovaBay previously generated revenue from eyecare and wound‑care segments, and a skincare line (DERMAdoctor) that has since been divested. Recent strategic moves include the sale of the Avenova brand and a pivot toward acquiring digital assets and participating in open digital financial networks. These changes reflect a broader effort to reposition the company away from its traditional medical product focus.
The reverse split aligns with NovaBay’s broader strategy to maintain exchange listing while it restructures its operations. Management has emphasized the importance of meeting listing standards and has highlighted the divestiture of legacy assets as a way to return value to shareholders. The split is therefore a tactical step to preserve market access while the company works to improve its financial footing.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.